Joel Greenblatt’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Joel Greenblatt's IBRX Position: Q3 2026 in Review
Joel Greenblatt sold out of ImmunityBio (IBRX) in Q3 2026, closing a stake of 175,564 shares — an estimated $1.54M sold.
Joel Greenblatt first reported a position in IBRX in Q2 2017 and held it in 9 quarters. The position peaked at $1.54M in Q2 2026. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Joel Greenblatt reported no remaining ImmunityBio position as of Q3 2026 after selling out during the quarter.
- Joel Greenblatt sold 175,564 ImmunityBio shares in Q3 2026, an estimated $1.54M.
- Joel Greenblatt first reported a position in ImmunityBio in Q2 2017 and held it in 9 quarters.
- Joel Greenblatt's ImmunityBio position peaked at $1.54M in Q2 2026.
- 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.